Emerging Concepts in Nutrigenomics: A Preview of What Is to Come

Abstract

This article provides an overview of the fundamental principles of genetics and emerging concepts related to the ways in which nutrients and bioactive food components may interact with the genome and subsequently affect human health. This exciting area of research is likely to have far-reaching implications for the assessment and treatment of critically and chronically ill individuals that will affect nutrition standards of care and practice. A brief overview of some of the ethical, legal, and social implications of genomic research and genome-based health care and a list of genetics resources also are provided.

Get full access to this article

View all access options for this article.

References

NIH News. US Department of Health and Human Services. International consortium completes human genome project: all goals achieved; new vision for genome unveiled. Available at: http://www.nih.gov/news/pr/apr2003/nhgri-14.htm. Accessed August 12, 2004.

Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research: a blueprint for the genomic era. Nature. 2003;422:835– 847.

Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res. 2004 ;551:51– 64.

US Department of Energy Office of Science. The science behind the Human Genome Project. Available at: http://www.ornl.gov/sci/techresources/Human_Genome/project/info.shtml#basics. Accessed August 9, 2004.

Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet. 2002 ;30:13– 19.

Nussbaum RL, McInnes RR, Willard HF. The human genome: structure and function of genes and chromosomes. In: Thompson and Thompson Genetics in Medicine. 6^th ed. New York, NY: W. B. Saunders; 2001: 17–32.

Nussbaum RL, McInnes RR, Willard HF. Principles of molecular disease: lessons from the hemoglobinopathies. In: Thompson and Thompson Genetics in Medicine. 6^th ed. New York, NY: W. B. Saunders; 2001:181– 202.

Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA. 2001 ;285:540– 544.

Guttmacher AE, Collins FS. Genomic medicine: a primer. N Engl J Med. 2002;347:1512– 1520.

10.

Nussbaum RL, McInnes RR, Willard HF. Patterns of single-gene inheritance. In: Thompson and Thompson Genetics in Medicine. 6^th ed. New York, NY: W. B. Saunders;2001 : 51–78.

11.

Stopler T. Medical nutritional therapy for anemia. In: Krause's Food Nutrition and Diet Therapy. 11^th ed. Philadelphia, PA: W. B. Saunders; 2004:838– 859.

12.

Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med. 2004 ;350:2383– 2397.

13.

Müller M, Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet. 2003 ;4:315– 322.

14.

Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 ;10:111– 113.

15.

Malinow MR, Nieto FJ, Kruger WD, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase geno-types. Arterioscler Thromb Vasc Biol. 1997;17:1157– 1162.

16.

Ashfield-Watt PAL, Pullin CH, Whiting JM, et al. Methylenetetrahydrofolate reductase 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr. 2002;76:180– 186.

17.

Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996 ;93:7– 9.

18.

Rosenberg IH, Rosenberg LE. The implications of genetic diversity for nutrient requirements: the case of folate. Nutr Rev. 1998;56:S47– S53.

19.

Schwahn B, Rozen R. Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenom. 2001;1:189– 201.

20.

Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997 ;57:1098– 1102.

21.

Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet. 1999;84:151– 157.

22.

Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862– 877.

23.

Svetkey LP, Moore TJ, Simons-Morton DG, et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens. 2001 ;19:1949– 1956.

24.

Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am J Clin Nutr. 1999 ;70:566– 571.

25.

Price PT, Nelson CM, Clarke SD. Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol. 2000 ;11:3– 7.

26.

Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci USA. 2001;98:392– 394.

27.

Balter M. Genetics: was Lamarck just a little bit right? Science. 2000;288:38 .

28.

Verma M, Dunn BK, Ross S, et al. Early detection and risk assessment: proceedings and recommendations from the Work-shop on Epigenetics in Cancer Prevention. Ann N Y Acad Sci. 2003 ;983:298– 319.

29.

Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004 ;429:457– 463.

30.

Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002 ;16:6– 21.

31.

Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004 ;20:63– 68.

32.

Rampersaud GC, Bailey LB, Kauwell GPA. Relationship of folate to colorectal and cervical cancer: review and recommendations for practitioners. J Am Diet Assoc. 2002 ;102:1273– 1282.

33.

Jacob RA, Gretz DM, Taylor PC, et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr. 1998 ;128:1204– 1212.

34.

Rampersaud GC, Kauwell GPA, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am J Clin Nutr. 2000 ;72:998– 1003.

35.

Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999;286:481– 486.

36.

Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23:5293– 5300.

37.

Miltenberger RJ, Mynatt RL, Wilkinson JE, Woychik RP. The role of the agouti gene in the yellow obese syndrome. J Nutr. 1997;127:S1902– S1907.

38.

Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of off-spring. J Nutr. 2002;197(suppl):S2392– S2400.

39.

Choi S-W, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000 ;130:129– 132.

40.

Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997 ;94:3290– 3295.

41.

Pardanani A, Wieben ED, Spelsberg TC, Tefferi A. Primer on medical genomics, part IV: expression proteomics. Mayo Clin Proc. 2002;77:1185– 1196.

42.

Fields S. Proteomics: proteomics in genomeland. Science. 2001;291 :1221– 1224.

43.

Kvasni[caron]cka F. Proteomics: general strategies and application to nutritionally relevant proteins. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;787:77– 89.

44.

German JB, Roberts MA, Fay L, Watkins SM. Metabolomics and individual metabolic assessment: the next great challenge for nutrition. J Nutr. 2002;132:2486– 2487.

45.

German JB, Roberts MA, Watkins SM. Personal metabolomics as a next generation nutritional assessment. J Nutr. 2003 ;133:4260– 4266.

46.

Garlow SJ. And now, transcriptomics. Neuron. 2002;34:327– 328.

47.

Hegde PS, White IR, Debouck C. Interplay of transcriptomics and proteomics. Curr Opin Biotechnol. 2003 ;14:647– 651.

48.

Connolly SB, Sadlier D, Kieran NE, Doran P, Brady HR. Transcriptome profiling and the pathogenesis of diabetic complications. J Am Soc Nephrol. 2003;14(suppl):S279– S283.

49.

Weinshilboum R. Inheritance and drug response. N Engl J Med. 2003;348:529– 537.

50.

Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature. 2004 ;429:464– 468.

51.

Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics. 2004 ;16:166– 177.

52.

van Ommen B, Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol. 2002;13:517– 521.

53.

Ghazalpour A, Doss S, Yang X, et al. Thematic review series: the pathogenesis of atherosclerosis: toward a biological network for atherosclerosis. J Lipid Res. 2004 ;45:1793– 1805.

54.

Hampton T. Physicians apply genome research to treating critical illness and injury. JAMA. 2004 ;291:287– 288.

55.

Hopf HW. Molecular diagnostics of injury and repair responses in critical illness: what is the future of “monitoring” in the intensive care unit? Crit Care Med. 2003 ;31(suppl):S518– S523.

56.

Yende S, Quasney MW, Tolley EA, Wunderink RG. Clinical relevance of angiotensin-converting enzyme gene polymorphisms to predict risk of mechanical ventilation after coronary artery bypass graft surgery. Crit Care Med. 2004;32:922– 927.

57.

Volzke H, Engel J, Kleine V, et al. Angiotensin I-converting enzyme insertion/deletion polymorphism and cardiac mortality and morbidity after coronary artery bypass graft surgery. Chest. 2002 ;122:31– 36.

58.

Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2002;166:646– 650.

59.

Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med. 2003;349:996– 998.

60.

Gollust SE, Hull SC, Wilfond BS. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA. 2002 ;288:1762– 1767.

61.

Gollust SE, Wilfond BS, Hull SC. Direct-to-consumer sales of genetic services on the Internet. Genet Med. 2003 ;5:332– 337.